Fisetin enhances cisplatin sensitivity in renal cell carcinoma via the CDK6/PI3K/Akt/mTOR signaling pathway

Tingting Jiang(Hangzhou Hospital of Traditional Chinese Medicine), Yin Xue(Hangzhou Hospital of Traditional Chinese Medicine)
Oncology Letters
February 20, 2024
Cited by 4


Related Papers